Chad and Mary welcome Chris Hansen, PhD, Divisional General Manager for the Rare Disease Medical Affairs team, East, with Sanofi. This conversation explores the transition from traditional metrics to a more meaningful impact-driven approach in the field. Chris shares his journey, insights on the importance of both qualitative and quantitative metrics, and how to drive meaningful interactions with healthcare professionals. The discussion emphasizes the need for a holistic view of success in medical affairs, integrating both types of metrics to truly assess impact. In this conversation, Chris Hansen discusses the evolving landscape of medical affairs metrics, emphasizing the need for a holistic approach to measuring success.